GYL Financial Synergies’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $741K | Sell |
14,322
-4,779
| -25% | -$247K | 0.06% | 207 |
|
|
2024
Q2 | $793K | Sell |
19,101
-3,636
| -16% | -$151K | 0.06% | 197 |
|
|
2024
Q1 | $1.23M | Sell |
22,737
-3,828
| -14% | -$208K | 0.1% | 167 |
|
|
2023
Q4 | $1.36M | Sell |
26,565
-1,984
| -7% | -$102K | 0.11% | 157 |
|
|
2023
Q3 | $1.66M | Sell |
28,549
-24,127
| -46% | -$1.4M | 0.16% | 125 |
|
|
2023
Q2 | $3.37M | Buy |
52,676
+41,178
| +358% | +$2.63M | 0.31% | 80 |
|
|
2023
Q1 | $797K | Buy |
11,498
+2,708
| +31% | +$188K | 0.1% | 142 |
|
|
2022
Q4 | $632K | Buy |
8,790
+1,222
| +16% | +$87.9K | 0.14% | 106 |
|
|
2022
Q3 | $538K | Buy |
7,568
+3
| +0% | +$213 | 0.15% | 96 |
|
|
2022
Q2 | $582K | Buy |
7,565
+1,820
| +32% | +$140K | 0.16% | 88 |
|
|
2022
Q1 | $420K | Sell |
5,745
-250
| -4% | -$18.3K | 0.1% | 123 |
|
|
2021
Q4 | $374K | Buy |
5,995
+1,123
| +23% | +$70.1K | 0.1% | 147 |
|
|
2021
Q3 | $288K | Buy |
4,872
+1,858
| +62% | +$110K | 0.15% | 148 |
|
|
2021
Q2 | $201K | Sell |
3,014
-469
| -13% | -$31.3K | 0.1% | 181 |
|
|
2021
Q1 | $220K | Buy |
3,483
+3
| +0.1% | +$189 | 0.12% | 164 |
|
|
2020
Q4 | $216K | Sell |
3,480
-702
| -17% | -$43.6K | 0.12% | 160 |
|
|
2020
Q3 | $252K | Buy |
+4,182
| New | +$252K | 0.17% | 135 |
|
|
2020
Q1 | – | Sell |
-3,607
| Closed | -$232K | – | 146 |
|
|
2019
Q4 | $232K | Buy |
+3,607
| New | +$232K | 0.1% | 163 |
|